Julie Myint
Symbiosis IP
-Director & Patent Attorney
Intellectual Property
Cardiff, Wales
← Back To Search Results
Symbiosis IP
-Director & Patent Attorney
Intellectual Property
Cardiff, Wales
Julie Myint is a qualified Chartered UK Patent Attorney, and Registered European Patent Attorney. She established Symbiosis IP in 2008 to specialise in the life science sector and to service the UK academic community their spin-outs and corporate partners.
Julie has worked within the academic innovation environment since 1992, specialising in patent prosecution throughout the world, thus gaining valuable knowledge about international patent prosecution and how to achieve success in different countries. Some of the firm’s academic clients she began working with in 1995, others in the early 2000s, in a strongly competitive market, this is a testament to the value she can bring to patent portfolios.
Over the past 25 years, with her work colleagues, she has carefully built a network of international IP attorneys in key jurisdictions who offer the same excellent service and competitive charging rates that clients and affiliates of Symbiosis expect.
Julie is experienced in Oral Proceedings and Opposition procedures before the European Patent Office and Hearings at the UK IPO and she also has experience of dispute resolution in relation to inventorship, infringement and freedom to operate.
Julie is registered to act before the UPC.
Julie has a wealth of experience in obtaining protection for vaccines; diagnostics; plant-derived medicaments; ocular treatments; antimicrobials; therapeutics; drug repurposing; stem cells; immunotherapies; gene therapies; in vitro cell models; and medical devices.
"I enjoy taking complex matters and distilling them down to what really matters then presenting the result to the client in such a way that everything suddenly becomes clear. This is my add-on value and I think it’s important because once the client clearly understands their IP issues, they can make confident management decisions.
This approach is particularly needed when providing due diligence and freedom-to-operate advice."